In Re: Zantac (Ranitidine) Products Liability Litigation
This legal case involves several plaintiffs who are suing multiple pharmaceutical companies and retailers for allegedly conspiring to fix prices of generic drugs. Additionally, the manufacturers and distributors of Zantac are being sued for personal injuries caused by the drug's high levels of NDMA, a probable carcinogen. The plaintiffs argue that the defendants engaged in anticompetitive behavior and were negligent in their handling of Zantac, which contains NDMA. The lawsuits seek damages for injuries, including cancer, and claim that the defendants failed to warn consumers of the potential risks associated with the drug. The lawsuits were filed in the United States District Court for the Southern District of Florida.
Read Next